ISHARES TR - GENOMICS IMMUN (IDNA)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / GENOMICS IMMUN
Shares, excl. options Q1 2024
1.7 M
Holdings value Q1 2024
$40.9 M
Value change Q1 2024
-$4.03 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
57
Number of buys Q1 2024
20
Number of sells Q1 2024
-29
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
46435U192
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.7 M $40.9 M -$4.03 M $24.08 57
2023 Q4 1.87 M $43.1 M +$5.82 M $23.01 63
2023 Q3 1.62 M $32.9 M -$4.99 M $20.35 62
2023 Q2 2.04 M $47.7 M +$557 K $23.35 64
2023 Q1 2.02 M $47.1 M +$3.45 M $23.27 71
2022 Q4 1.75 M $43.9 M +$525 K $25.17 70
2022 Q3 1.76 M $46.6 M -$4.2 M $26.39 61
2022 Q2 1.9 M $55 M -$8.77 M $28.90 62
2022 Q1 2.12 M $73.1 M -$21.7 M $34.45 76
2021 Q4 2.59 M $115 M +$23.2 M $43.81 98
2021 Q3 2.04 M $108 M +$8.14 M $50.71 84
2021 Q2 1.88 M $103 M +$1.11 M $52.03 81
2021 Q1 1.87 M $89.8 M +$20 M $45.71 77
2020 Q4 1.42 M $65.1 M +$14.9 M $45.94 61
2020 Q3 1.11 M $43.3 M +$10.5 M $38.96 44
2020 Q2 850 K $29.7 M +$17.5 M $37.96 32
2020 Q1 234 K $6.28 M +$6.27 M $26.87 1
2019 Q4 735 K $22 M -$2.53 M $30.00 3
2019 Q3 820 K $20.1 M +$14.3 M $26.96 2
2019 Q2 232 K $6.32 M +$6.32 M $27.17 3